Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PROTEOMICS -- Ignore unavailable to you. Want to Upgrade?

To: Jongmans who wrote (172)	12/1/2000 3:32:44 AM
From: nigel bates	Read Replies (1) \| Respond to of 539

SYDNEY, Australia, and PLANO, Texas, Nov. 30 /PRNewswire/ -- Proteome Systems Ltd. and MicroFab Technologies Inc. today announced that they have reached agreement to utilize MicroFab's patented MatrixJet Technology in Proteome Systems' proteomics technology platform instruments in an exclusive arrangement. MatrixJet is a configurable, multifluid, integrated array ink-jet printhead technology for dispensing biologically active fluids. MatrixJet allows the number of fluids, the number of jets and the spacing of the jets to be adjusted to fit the application, but in an integrated assembly that provides for greater ease of use and higher density than other ink-jet systems. Proteome Systems is currently employing the Matrix 10 printhead for dispensing up to ten different fluids from a single assembly in its Chemical Printer program. MicroFab and Proteome Systems plan to extend their collaboration in the future to develop new MatrixJet designs for Proteomic analysis. Proteome Systems, with over 60 employees in Sydney and Boston, is one of a small group of companies globally with the capacity to conduct large-scale proteomics. Proteome Systems is a leading innovator it the development of high throughput proteomics platforms with its technology partners. It is also pioneering bioinformatic aspects of proteomics. Headquartered in Plano, Texas, MicroFab Technologies develops and commercializes new technology aimed at enabling high-payoff applications for microdispensing and precision printing in a wide range of industries and applications. Electronic and photonic manufacturing methods and equipment being developed have been used to create microlenses, waveguides, display pixels, electronic passives, and solder bumps with feature sizes down to 20mm using a data-driven, additive process. Biomedical applications being developed at MicroFab include fabrication of biochip arrays containing DNA, proteins, and peptides. MicroFab has recently spun out two start-up companies: AromaJet.com, developing methods and equipment for delivering odors and flavors for consumer, industrial, and medical applications; and OptoPak, developing microoptic components and assemblies for the Telecom and Datacom industries. For further information on MicroFab please visit our web site at: www.microfab.com For further information please contact: proteomesystems.com .